RigsHeart 🫀🚨 (@rigsheart) 's Twitter Profile
RigsHeart 🫀🚨

@rigsheart

Official account of the Department of Cardiology, Copenhagen University Hospital, Rigshospitalet, Denmark

ID: 1525884049449013248

calendar_today15-05-2022 17:01:32

950 Tweet

1,1K Takipçi

367 Takip Edilen

Jani Thuraiaiyah (@jani_md_) 's Twitter Profile Photo

Proud to share that I have officially been awarded my PhD. A significant milestone marking years of hard work, learning, and growth. Thank you to everyone who supported me along the way! 🫀🫶

RigsHeart 🫀🚨 (@rigsheart) 's Twitter Profile Photo

📢 Two more PhD defences coming up before April ends! - lncidence, diagnostic challenges, patient characteristics, and outcomes in patients with prosthetic valve endocarditis - Epidemiology of Long-Term Morbidity and Mortality in Adult Congenital Heart Disease Join us in

📢 Two more PhD defences coming up before April ends!

- lncidence, diagnostic challenges, patient characteristics, and outcomes in patients with prosthetic valve endocarditis

- Epidemiology of Long-Term Morbidity and Mortality in Adult Congenital Heart Disease

Join us in
RigsHeart 🫀🚨 (@rigsheart) 's Twitter Profile Photo

Just out 📢Outcomes of mitral valve reoperation and first-time surgery for mitral regurgitation: A nationwide study 🇩🇰 By Dr Sofie Truong in International Journal of Cardiology 📰 ➡️ Patients undergoing reoperation have high burden of comorbidities despite young age. ➡️ Mortality was 7.1 % following

Just out 📢Outcomes of mitral valve reoperation and first-time surgery for mitral regurgitation: A nationwide study 🇩🇰 By Dr Sofie Truong in <a href="/IJCardio/">International Journal of Cardiology</a> 📰

➡️ Patients undergoing reoperation have high burden of comorbidities despite young age.
➡️ Mortality was 7.1 % following
RigsHeart 🫀🚨 (@rigsheart) 's Twitter Profile Photo

Just out 📢 Efficacy of the Glucagon-Like Peptide-1 Agonist Exenatide in Patients Undergoing CABG or Aortic Valve Replacement: A Randomized Double-Blind Clinical Trial in Circulation Exenatide infusion before and during cardiopulmonary bypass has no effect on the risk of a

Just out 📢
Efficacy of the Glucagon-Like Peptide-1 Agonist Exenatide in Patients Undergoing CABG or Aortic Valve Replacement: A Randomized Double-Blind Clinical Trial in <a href="/CircAHA/">Circulation</a> 

Exenatide infusion before and during cardiopulmonary bypass has no effect on the risk of a
RigsHeart 🫀🚨 (@rigsheart) 's Twitter Profile Photo

Just out 📢 Previous total knee or total hip arthroplasty and association with amyloidosis – a Danish nationwide study 🏥 🫀 🇩🇰 Navid Noory Eva Havers-Borgersen Oscar Westin Finn Gustafsson Emil Fosbøl Read more tandfonline.com/doi/full/10.10…

RigsHeart 🫀🚨 (@rigsheart) 's Twitter Profile Photo

Just out ❗️ This combined analysis of two randomized #MRA trials of patients with #HFrEF, by Jawad Haider Butt MD, shows that ❗️the benefit of mineralocorticoid receptor antagonist vs placebo on HF hospitalizations was greater with higher weight at baseline ❗️this pattern was more

Just out ❗️

This combined analysis of two randomized #MRA trials of patients with #HFrEF, by <a href="/JawadHButt/">Jawad Haider Butt MD</a>, shows that
❗️the benefit of mineralocorticoid receptor antagonist vs placebo on HF hospitalizations was greater with higher weight at baseline
 ❗️this pattern was more
RigsHeart 🫀🚨 (@rigsheart) 's Twitter Profile Photo

Feel free to join the webinar "Preventing and Improving Outcomes in Sudden Cardiac Arrest" by ERN GUARD-Heart prof Jacob Tfelt-Hansen Featuring Dr. Bo Gregers Winkel from RigsHeart 🫀🚨 , along with Dr. Andrea Greco and Dr. Cristina Basso🩺🫀 Moderators: Dr. Elena Arbelo and Dr. Georgia

Arif Khokhar (@drarifk) 's Twitter Profile Photo

UNICORN-assisted Redo-TAVR ⚠️ Sapien-in-Acurate ⛔️ High CO Risk 🛠️ Planning w/ Bench-testing ✅ Preserved coronary flow Making the Unfeasible -> Feasible. RigsHeart 🫀🚨 Yusuke Kobari Lim Yinghao Yannick Willemen

RigsHeart 🫀🚨 (@rigsheart) 's Twitter Profile Photo

Don't miss the PhD Defence by Peter Laursen Graversen 📍Today at 2 PM, Auditorium 1, Rigshospitalet He is defending his thesis named: Surgical treatment for infective endocarditis 🫀🦠🩺

RigsHeart 🫀🚨 (@rigsheart) 's Twitter Profile Photo

Yesterday, another PhD was successfully defended by Peter Laursen Graversen Congratulations! 🎓👏 We now better understand the surgical treatment for endocarditis - a complex and life threatening condition 🫀🦠

Yesterday, another PhD was successfully defended by <a href="/plgraversen/">Peter Laursen Graversen</a>

Congratulations! 🎓👏

We now better understand the  surgical treatment for endocarditis - a complex and life threatening condition 🫀🦠
RigsHeart 🫀🚨 (@rigsheart) 's Twitter Profile Photo

📊 Sneak peek! Christina Byrne and team validated the NULL-PLEASE score in 3,881 OHCA patients 🇩🇰 🔢 Score ≥9 = 98% chance of death or brain injury 🧠 But: outliers exist! AUCs around 0.8. That’s no joke. Big win for resus prognostication! academic.oup.com/ehjacc/advance…